Skip to main content
Clinical Trials/IRCT20200529047594N1
IRCT20200529047594N1RecruitingPhase 3

Comparison of efficacy & safety of intratracheal Beraksurf with Survanta and Curosurf in preterm newborns with Respiratory distress syndrome (RDS)

Iran University of Medical Sciences0 sites90 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 day to 2 days (—)
Sex
All

Inclusion Criteria

  • Parents consent to participate study
  • premature neonates with a gestational age of less than 34 weeks
  • premature neonates with diagnosis of RDS and candidates for surfactant
  • A maximum of 8 hours have elapsed since the birth

Exclusion Criteria

  • No parents consent to participate study
  • Newborns with congenital heart diseases and other life threatening congenital anomalies.
  • Adverse drug effects

Investigators

Similar Trials